No Prescription |
 |
 | ||
|
ATORVA Lipitor |
|
| ||
No Prescription » Prescription Drugs 2 » ATORVA Lipitor Atorvastatin (a-TOR-va-stat-in) is used to lower cholesterol and triglyceride (fat-like substances) levels in the blood. Using this medicine may help prevent medical problems caused by such substances clogging the blood vessels. This medicine may also be used to prevent certain types of heart problems in adults with risk factors for heart problems.Atorvastatin belongs to the group of medicines called 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. It works by blocking an enzyme that is needed by the body to make cholesterol thereby reducing the amount of cholesterol in the blood.Atorvastatin is a cholesterol-lowering drug. Your doctor may prescribe it along with a special diet if your blood cholesterol or triglyceride level is high and you have been unable to lower your readings by diet alone. The drug works by helping to clear harmful low-density lipoprotein (LDL) cholesterol out of the blood and by limiting the body's ability to form new LDL cholesterol.Your doctor may prescribe Atorvastatin to reduce your chances of having a heart attack or developing heart disease if you have any of the following risk factors:Are age 55 years or older. Smoke. Have high blood pressure. Have low levels of HDL (high-density lipoprotein--the good cholesterol). Have a family history of early heart disease. For people at high risk of heart disease the doctor may suggest a cholesterol-lowering medication if LDL readings are 130 or more. For those at low risk a medication is considered at readings of 190 or more.Lowering high cholesterol and triglycerides in certain patients. It also increases high-density lipoprotein (HDL "good") cholesterol levels. It is used along with an appropriate diet. It is used in certain patients to reduce the risk of heart attack stroke chest pain caused by angina or blood vessel blockage. It is also used in certain patients to reduce the risk of hospitalization for congestive heart failure or the need for medical procedures to open blocked heart blood vessels. It may also be used for other conditions as determined by your doctor. Buy ATORVA Lipitor and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About ATORVA Lipitor: Product Type: Prescription Drugs 2 ATORVA ( Lipitor Generic Atorvastatin ) ATORVA (Lipitor Generic Atorvastatin) Lipitor Generic Atorvastatin 40mg tabs 180 ( 10 x 18 ) 30 ( 10 x 3 ) 90 ( 10 x 9 ) 60 ( 10 x 6 ) Lipitor Generic Atorvastatin ATORVA
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
